Jiang Su Yida Chemical (SZ:300721) Xin Lang Cai Jing·2026-02-03 07:49Core Viewpoint - The company Yida Co., Ltd. announced that its subsidiary, Taixing Yida Chemical Co., Ltd., plans to absorb and merge its wholly-owned subsidiary, Wanqi Biotechnology (Taizhou) Co., Ltd. [1] Financial Summary - As of September 30, 2025, Taixing Yida has total assets of 1.358 billion yuan and total liabilities of 1.368 billion yuan, with revenue of 225 million yuan and a net loss of 126 million yuan for the first nine months of 2025 [1] - As of November 18, 2025, Wanqi Biotechnology has total assets of 7.1882 million yuan and total liabilities of 110,700 yuan, with no revenue and a net loss of 2.8632 million yuan for the period from January 1 to November 18, 2025 [1] Merger Details - The absorption and merger will not involve any payment of consideration, and upon completion, the legal entity of Wanqi Biotechnology will be canceled [1]